Watson syndrome

Description

Watson syndrome, also known as Watson-Ware syndrome, is a rare genetic disorder characterized by several distinct physical and intellectual features.

Physical Features:

  • Pulmonic stenosis: A heart condition where the pulmonary valve is narrowed or blocked, obstructing blood flow from the right ventricle to the lungs.
  • Café-au-lait spots: Light brown or coffee-colored patches on the skin, typically found on the face, trunk, and limbs.
  • Short stature: Most patients with Watson syndrome have short stature, which can range from mild to severe.

Intellectual Features:

  • Decreased intellectual ability: Patients with Watson syndrome often have below-average intelligence, ranging from mild to moderate mental retardation.
  • Dull intelligence: Some sources describe the intellectual impairment as "dull" or "low normal".

Other Features:

  • Macrocephaly: Some patients may have an enlarged head size (macrocephaly).
  • Neurofibromas: Rarely, patients with Watson syndrome may develop neurofibromas, which are non-cancerous tumors on nerve tissue.

Watson syndrome is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to

Additional Characteristics

  • Macrocephaly
  • Short stature
  • Neurofibromas
  • Pulmonic stenosis
  • Café-au-lait spots
  • Decreased intellectual ability

Signs and Symptoms

Watson syndrome, also known as Watson syndrome variant of neurofibromatosis type 1, is a rare genetic disorder characterized by several distinct signs and symptoms.

Common Signs and Symptoms:

  • Pulmonary valvular stenosis: A narrowing of the pulmonary valve that can lead to heart problems.
  • Cafe-au-lait spots: Light brown or coffee-colored skin patches that are usually present at birth.
  • Low-normal intelligence: Affected individuals may have below-average cognitive abilities.
  • Short stature: People with Watson syndrome often grow shorter than average.

Additional Symptoms:

  • Relative macrocephaly: A slightly larger-than-average head size.
  • Lisch nodules: Small, pigmented spots on the iris of the eye.
  • Neurofibromas: Benign tumors that grow along nerves and their branches.
  • Cutaneous neurofibromas: Tumors that appear on the skin.

Other Possible Symptoms:

  • Mental impairment
  • Seizures
  • Visual abnormalities
  • Cysts in the lungs

It's essential to note that not all individuals with Watson syndrome will exhibit all of these symptoms, and the severity can vary from person to person. A diagnosis is typically made by a pediatrician or neurologist based on a combination of clinical evaluation, medical history, and genetic testing.

References:

  • [1] Partington et al. (1985) described a father, daughter, and son with Watson syndrome, highlighting the presence of cafe-au-lait spots, low-normal intelligence, and short stature.
  • [2] Allanson et al. (1991) reported on the occurrence of neurofibromas in about one-third of individuals with Watson syndrome.
  • [3] Watson (1967) initially described 15 persons from three families with pulmonic stenosis, cafe-au-lait spots, and low-normal intelligence.

Please let me know if you'd like me to expand on any of these points or provide further information!

Additional Symptoms

  • Seizures
  • Relative macrocephaly
  • Neurofibromas
  • Pulmonary valvular stenosis
  • Cafe-au-lait spots
  • Low-normal intelligence
  • Lisch nodules
  • Cutaneous neurofibromas
  • Mental impairment
  • Visual abnormalities
  • Cysts in the lungs
  • short stature

Diagnostic Tests

Watson syndrome is a rare genetic disorder characterized by pulmonic stenosis, cafe-au-lait spots, decreased intellectual ability, and short stature.

Diagnostic tests for Watson syndrome may include:

  • Physical examination to look for characteristic features such as pulmonic stenosis, cafe-au-lait spots, and short stature [8]
  • Magnetic resonance imaging (MRI) to determine the extent of plexiform neurofibromas [6]
  • Molecular genetic testing to analyze the NF1 gene, which is associated with Watson syndrome and other related conditions [4]

It's worth noting that:

  • The diagnosis of Watson syndrome is most likely made by a pediatrician, possibly in consultation with a neurologist and an ophthalmologist [5]
  • No specific treatment or cure exists for Watson syndrome, but diagnostic testing can inform prognosis and management [5]

References: [4] Analyzes the NF1 gene, which is associated with NF1-related conditions, including neurofibromatosis type 1 and Watson syndrome. [5] Diagnosis and Prognosis: The diagnosis is most likely made by a pediatrician, perhaps in consultation with a neurologist and an ophthalmologist. No treatment ... [6] Magnetic resonance imaging can determine the extent of plexiform neurofibromas. Molecular genetic testing can be requested but is mostly not needed. [8] Watson syndrome is an autosomal dominant disorder characterized by pulmonic stenosis, cafe-au-lait spots, decreased intellectual ability (Watson, 1967), and ...

Additional Diagnostic Tests

  • Physical examination
  • Magnetic resonance imaging (MRI)
  • Molecular genetic testing

Treatment

Watson syndrome, also known as Watson-Albright disease, is a rare genetic disorder that affects bone growth and development. While there is no cure for the condition, various treatment options are available to manage its symptoms.

Treatment Options

According to recent studies [5], new therapeutic and preventive options have been explored for Watson syndrome, including:

  • Tyrosine kinase inhibitors
  • mTOR inhibitors
  • Interferons
  • Radiofrequency therapy

These treatments aim to alleviate the symptoms of Watson syndrome, such as bone deformities and growth abnormalities.

Additional Therapies

In some cases, additional therapies may be necessary to manage the condition. These can include:

  • Special diets and nutritional supplementation to ensure proper absorption of vitamins A, D, E, and K [6]
  • Medications like rifampin or naltrexone to provide relief from symptoms [7]

It's essential to note that these treatment options are not specific to Watson syndrome but may be considered as part of a broader therapeutic approach.

Genetic Management

Recent research has highlighted the importance of identifying NF1 variants in patients with Watson syndrome, as this can aid in their therapeutic management [9]. Whole-exome sequencing (WES) has been shown to be helpful in this regard.

While these treatment options and genetic management strategies are available, it's crucial to consult a qualified specialist for personalized advice on managing Watson syndrome.

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Watson syndrome, also known as Schinke-Watson syndrome, is a rare genetic disorder that presents with multiple café au lait macules (CALMs), intertriginous freckling, and other systemic features.

The differential diagnosis for Watson syndrome includes:

  • Neurofibromatosis 1 (NF1): This condition shares similar skin manifestations, including CALMs and neurofibromas. However, NF1 is a more common disorder with a broader range of systemic features [4][5].
  • McCune-Albright syndrome: This rare genetic disorder presents with polyostotic fibrous dysplasia, café au lait macules, and endocrine abnormalities. While it shares some skin manifestations with Watson syndrome, the presence of endocrine dysfunction is a key distinguishing feature [3].
  • Noonan syndrome with lentigines: This condition is characterized by facial dysmorphism, short stature, and multiple CALMs. However, the presence of lentigines (small, dark spots) on the skin is a distinctive feature that differentiates it from Watson syndrome [8][9].
  • Proteus syndrome: This rare genetic disorder presents with multiple CALMs, macrocephaly, and other systemic features. While it shares some similarities with Watson syndrome, the presence of overgrowth and other distinct features sets it apart [3].

It's essential to consider these differential diagnoses when evaluating patients with Watson syndrome-like symptoms, as accurate diagnosis is crucial for guiding management and genetic counseling.

References:

[1] by JM Friedman · 2022 · Cited by 605 — Neurofibromatosis 1 (NF1) is a multisystem disorder characterized by multiple café au lait macules, intertriginous freckling, multiple cutaneous neurofibromas,

[3] Other differential diagnoses include McCune-Albright syndrome, Noonan syndrome with lentigines and Proteus syndrome. Most cases of multiple non-ossifying ...

[4] Neurofibromatosis 1 (NF1) is a multisystem disorder characterized by multiple café au lait macules, intertriginous freckling, multiple cutaneous neurofibromas,

[8] by LOC Rodrigues · 2014 · Cited by 66 — a.​​ Watson syndrome CAL, Lisch, freckling, pulmonary stenosis, short stature, macrocephaly, cognitive deficits, neurofibromas.

[9] Oct 25, 2024 — The presence of numerous café au lait macules (CALMs) should raise the suspicion of a genetic disorder. The most common associated systemic ...

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2355
owl#annotatedSource
t350070
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070483
core#notation
DOID:0070483
oboInOwl#hasDbXref
MIM:193520
core#exactMatch
MIM:193520
IAO_0000115
A RASopathy characterized by pulmonic stenosis, cafe-au-lait macules, decreased intellectual ability, and short stature that has_material_basis_in heterozygous mutation in the NF1 gene on chromosome 17q11.2.
rdf-schema#label
Watson syndrome
rdf-schema#subClassOf
t349548
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.